Alzheimer's Disease Drug Market - Global Outlook and Forecast 2021-2027

March 2021 | 94 pages | ID: A8C8BCF671B1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Alzheimer's Disease Drug in global, including the following market information:

Global Alzheimer's Disease Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Alzheimer's Disease Drug Market Sales, 2016-2021, 2022-2027, (M Units)

Global top five Alzheimer's Disease Drug companies in 2020 (%)

The global Alzheimer's Disease Drug market was valued at 2039.6 million in 2020 and is projected to reach US$ 1307.1 million by 2027, at a CAGR of -10.5% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer's Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Alzheimer's Disease Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)

Global Alzheimer's Disease Drug Market Segment Percentages, By Type, 2020 (%)

• Donepezil
• Memantine
• Rivastigmine

Global Alzheimer's Disease Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)

Global Alzheimer's Disease Drug Market Segment Percentages, By Application, 2020 (%)

• Early to Moderate Stages
• Moderate to Severe Stages

Global Alzheimer's Disease Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)

Global Alzheimer's Disease Drug Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Alzheimer's Disease Drug revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Alzheimer's Disease Drug revenues share in global market, 2020 (%)

Key companies Alzheimer's Disease Drug sales in global market, 2016-2021 (Estimated), (M Units)

Key companies Alzheimer's Disease Drug sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Eisai
• Novartis
• Daiichi Sankyo
• Merz Pharma
• Pfizer
• Johnson & Johnson
• Lundbeck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Alzheimer's Disease Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Alzheimer's Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALZHEIMER'S DISEASE DRUG OVERALL MARKET SIZE

2.1 Global Alzheimer's Disease Drug Market Size: 2021 VS 2027
2.2 Global Alzheimer's Disease Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Alzheimer's Disease Drug Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Alzheimer's Disease Drug Players in Global Market
3.2 Top Global Alzheimer's Disease Drug Companies Ranked by Revenue
3.3 Global Alzheimer's Disease Drug Revenue by Companies
3.4 Global Alzheimer's Disease Drug Sales by Companies
3.5 Global Alzheimer's Disease Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Alzheimer's Disease Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Alzheimer's Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Drug Players in Global Market
  3.8.1 List of Global Tier 1 Alzheimer's Disease Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Alzheimer's Disease Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Alzheimer's Disease Drug Market Size Markets, 2021 & 2027
  4.1.2 Donepezil
  4.1.3 Memantine
  4.1.4 Rivastigmine
4.2 By Type - Global Alzheimer's Disease Drug Revenue & Forecasts
  4.2.1 By Type - Global Alzheimer's Disease Drug Revenue, 2016-2021
  4.2.2 By Type - Global Alzheimer's Disease Drug Revenue, 2022-2027
  4.2.3 By Type - Global Alzheimer's Disease Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Alzheimer's Disease Drug Sales & Forecasts
  4.3.1 By Type - Global Alzheimer's Disease Drug Sales, 2016-2021
  4.3.2 By Type - Global Alzheimer's Disease Drug Sales, 2022-2027
  4.3.3 By Type - Global Alzheimer's Disease Drug Sales Market Share, 2016-2027
4.4 By Type - Global Alzheimer's Disease Drug Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Alzheimer's Disease Drug Market Size, 2021 & 2027
  5.1.2 Early to Moderate Stages
  5.1.3 Moderate to Severe Stages
5.2 By Application - Global Alzheimer's Disease Drug Revenue & Forecasts
  5.2.1 By Application - Global Alzheimer's Disease Drug Revenue, 2016-2021
  5.2.2 By Application - Global Alzheimer's Disease Drug Revenue, 2022-2027
  5.2.3 By Application - Global Alzheimer's Disease Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Alzheimer's Disease Drug Sales & Forecasts
  5.3.1 By Application - Global Alzheimer's Disease Drug Sales, 2016-2021
  5.3.2 By Application - Global Alzheimer's Disease Drug Sales, 2022-2027
  5.3.3 By Application - Global Alzheimer's Disease Drug Sales Market Share, 2016-2027
5.4 By Application - Global Alzheimer's Disease Drug Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Alzheimer's Disease Drug Market Size, 2021 & 2027
6.2 By Region - Global Alzheimer's Disease Drug Revenue & Forecasts
  6.2.1 By Region - Global Alzheimer's Disease Drug Revenue, 2016-2021
  6.2.2 By Region - Global Alzheimer's Disease Drug Revenue, 2022-2027
  6.2.3 By Region - Global Alzheimer's Disease Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Alzheimer's Disease Drug Sales & Forecasts
  6.3.1 By Region - Global Alzheimer's Disease Drug Sales, 2016-2021
  6.3.2 By Region - Global Alzheimer's Disease Drug Sales, 2022-2027
  6.3.3 By Region - Global Alzheimer's Disease Drug Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Alzheimer's Disease Drug Revenue, 2016-2027
  6.4.2 By Country - North America Alzheimer's Disease Drug Sales, 2016-2027
  6.4.3 US Alzheimer's Disease Drug Market Size, 2016-2027
  6.4.4 Canada Alzheimer's Disease Drug Market Size, 2016-2027
  6.4.5 Mexico Alzheimer's Disease Drug Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Alzheimer's Disease Drug Revenue, 2016-2027
  6.5.2 By Country - Europe Alzheimer's Disease Drug Sales, 2016-2027
  6.5.3 Germany Alzheimer's Disease Drug Market Size, 2016-2027
  6.5.4 France Alzheimer's Disease Drug Market Size, 2016-2027
  6.5.5 U.K. Alzheimer's Disease Drug Market Size, 2016-2027
  6.5.6 Italy Alzheimer's Disease Drug Market Size, 2016-2027
  6.5.7 Russia Alzheimer's Disease Drug Market Size, 2016-2027
  6.5.8 Nordic Countries Alzheimer's Disease Drug Market Size, 2016-2027
  6.5.9 Benelux Alzheimer's Disease Drug Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Alzheimer's Disease Drug Revenue, 2016-2027
  6.6.2 By Region - Asia Alzheimer's Disease Drug Sales, 2016-2027
  6.6.3 China Alzheimer's Disease Drug Market Size, 2016-2027
  6.6.4 Japan Alzheimer's Disease Drug Market Size, 2016-2027
  6.6.5 South Korea Alzheimer's Disease Drug Market Size, 2016-2027
  6.6.6 Southeast Asia Alzheimer's Disease Drug Market Size, 2016-2027
  6.6.7 India Alzheimer's Disease Drug Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Alzheimer's Disease Drug Revenue, 2016-2027
  6.7.2 By Country - South America Alzheimer's Disease Drug Sales, 2016-2027
  6.7.3 Brazil Alzheimer's Disease Drug Market Size, 2016-2027
  6.7.4 Argentina Alzheimer's Disease Drug Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Alzheimer's Disease Drug Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Alzheimer's Disease Drug Sales, 2016-2027
  6.8.3 Turkey Alzheimer's Disease Drug Market Size, 2016-2027
  6.8.4 Israel Alzheimer's Disease Drug Market Size, 2016-2027
  6.8.5 Saudi Arabia Alzheimer's Disease Drug Market Size, 2016-2027
  6.8.6 UAE Alzheimer's Disease Drug Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Alzheimer's Disease Drug Major Product Offerings
  7.1.4 Allergan Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.1.5 Allergan Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Alzheimer's Disease Drug Major Product Offerings
  7.2.4 Eisai Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.2.5 Eisai Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Alzheimer's Disease Drug Major Product Offerings
  7.3.4 Novartis Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.3.5 Novartis Key News
7.4 Daiichi Sankyo
  7.4.1 Daiichi Sankyo Corporate Summary
  7.4.2 Daiichi Sankyo Business Overview
  7.4.3 Daiichi Sankyo Alzheimer's Disease Drug Major Product Offerings
  7.4.4 Daiichi Sankyo Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.4.5 Daiichi Sankyo Key News
7.5 Merz Pharma
  7.5.1 Merz Pharma Corporate Summary
  7.5.2 Merz Pharma Business Overview
  7.5.3 Merz Pharma Alzheimer's Disease Drug Major Product Offerings
  7.5.4 Merz Pharma Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.5.5 Merz Pharma Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Alzheimer's Disease Drug Major Product Offerings
  7.6.4 Pfizer Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.6.5 Pfizer Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Alzheimer's Disease Drug Major Product Offerings
  7.4.4 Johnson & Johnson Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.7.5 Johnson & Johnson Key News
7.8 Lundbeck
  7.8.1 Lundbeck Corporate Summary
  7.8.2 Lundbeck Business Overview
  7.8.3 Lundbeck Alzheimer's Disease Drug Major Product Offerings
  7.8.4 Lundbeck Alzheimer's Disease Drug Sales and Revenue in Global (2016-2021)
  7.8.5 Lundbeck Key News

8 GLOBAL ALZHEIMER'S DISEASE DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Alzheimer's Disease Drug Production Capacity, 2016-2027
8.2 Alzheimer's Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Alzheimer's Disease Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ALZHEIMER'S DISEASE DRUG SUPPLY CHAIN ANALYSIS

10.1 Alzheimer's Disease Drug Industry Value Chain
10.2 Alzheimer's Disease Drug Upstream Market
10.3 Alzheimer's Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Alzheimer's Disease Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Alzheimer's Disease Drug in Global Market
Table 2. Top Alzheimer's Disease Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Alzheimer's Disease Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Alzheimer's Disease Drug Revenue Share by Companies, 2016-2021
Table 5. Global Alzheimer's Disease Drug Sales by Companies, (M Units), 2016-2021
Table 6. Global Alzheimer's Disease Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Alzheimer's Disease Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Alzheimer's Disease Drug Product Type
Table 9. List of Global Tier 1 Alzheimer's Disease Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer's Disease Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Alzheimer's Disease Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Alzheimer's Disease Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Alzheimer's Disease Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Alzheimer's Disease Drug Sales (M Units), 2016-2021
Table 15. By Type - Global Alzheimer's Disease Drug Sales (M Units), 2022-2027
Table 16. By Application – Global Alzheimer's Disease Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Alzheimer's Disease Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Alzheimer's Disease Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Alzheimer's Disease Drug Sales (M Units), 2016-2021
Table 20. By Application - Global Alzheimer's Disease Drug Sales (M Units), 2022-2027
Table 21. By Region – Global Alzheimer's Disease Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Alzheimer's Disease Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Alzheimer's Disease Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Alzheimer's Disease Drug Sales (M Units), 2016-2021
Table 25. By Region - Global Alzheimer's Disease Drug Sales (M Units), 2022-2027
Table 26. By Country - North America Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Alzheimer's Disease Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Alzheimer's Disease Drug Sales, (M Units), 2016-2021
Table 29. By Country - North America Alzheimer's Disease Drug Sales, (M Units), 2022-2027
Table 30. By Country - Europe Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Alzheimer's Disease Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Alzheimer's Disease Drug Sales, (M Units), 2016-2021
Table 33. By Country - Europe Alzheimer's Disease Drug Sales, (M Units), 2022-2027
Table 34. By Region - Asia Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Alzheimer's Disease Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Alzheimer's Disease Drug Sales, (M Units), 2016-2021
Table 37. By Region - Asia Alzheimer's Disease Drug Sales, (M Units), 2022-2027
Table 38. By Country - South America Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Alzheimer's Disease Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Alzheimer's Disease Drug Sales, (M Units), 2016-2021
Table 41. By Country - South America Alzheimer's Disease Drug Sales, (M Units), 2022-2027
Table 42. By Country - Middle East & Africa Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Alzheimer's Disease Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Alzheimer's Disease Drug Sales, (M Units), 2016-2021
Table 45. By Country - Middle East & Africa Alzheimer's Disease Drug Sales, (M Units), 2022-2027
Table 46. Allergan Corporate Summary
Table 47. Allergan Alzheimer's Disease Drug Product Offerings
Table 48. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Eisai Corporate Summary
Table 50. Eisai Alzheimer's Disease Drug Product Offerings
Table 51. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Novartis Corporate Summary
Table 53. Novartis Alzheimer's Disease Drug Product Offerings
Table 54. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Daiichi Sankyo Corporate Summary
Table 56. Daiichi Sankyo Alzheimer's Disease Drug Product Offerings
Table 57. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Merz Pharma Corporate Summary
Table 59. Merz Pharma Alzheimer's Disease Drug Product Offerings
Table 60. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Alzheimer's Disease Drug Product Offerings
Table 63. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Johnson & Johnson Corporate Summary
Table 65. Johnson & Johnson Alzheimer's Disease Drug Product Offerings
Table 66. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Lundbeck Corporate Summary
Table 68. Lundbeck Alzheimer's Disease Drug Product Offerings
Table 69. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Alzheimer's Disease Drug Production Capacity (M Units) of Key Manufacturers in Global Market, 2019-2021 (M Units)
Table 71. Global Alzheimer's Disease Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 72. Global Alzheimer's Disease Drug Production by Region, 2016-2021 (M Units)
Table 73. Global Alzheimer's Disease Drug Production by Region, 2022-2027 (M Units)
Table 74. Alzheimer's Disease Drug Market Opportunities & Trends in Global Market
Table 75. Alzheimer's Disease Drug Market Drivers in Global Market
Table 76. Alzheimer's Disease Drug Market Restraints in Global Market
Table 77. Alzheimer's Disease Drug Raw Materials
Table 78. Alzheimer's Disease Drug Raw Materials Suppliers in Global Market
Table 79. Typical Alzheimer's Disease Drug Downstream
Table 80. Alzheimer's Disease Drug Downstream Clients in Global Market
Table 81. Alzheimer's Disease Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Alzheimer's Disease Drug Segment by Type
Figure 2. Alzheimer's Disease Drug Segment by Application
Figure 3. Global Alzheimer's Disease Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Alzheimer's Disease Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Alzheimer's Disease Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Alzheimer's Disease Drug Sales in Global Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Alzheimer's Disease Drug Revenue in 2020
Figure 9. By Type - Global Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Alzheimer's Disease Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Alzheimer's Disease Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 19. US Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 24. Germany Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 33. China Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 40. Brazil Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Alzheimer's Disease Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Alzheimer's Disease Drug Sales Market Share, 2016-2027
Figure 44. Turkey Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Alzheimer's Disease Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Alzheimer's Disease Drug Production Capacity (M Units), 2016-2027
Figure 49. The Percentage of Production Alzheimer's Disease Drug by Region, 2020 VS 2027
Figure 50. Alzheimer's Disease Drug Industry Value Chain
Figure 51. Marketing Channels